Literature DB >> 33288474

Sensitive structural and functional measurements and 1-year pulmonary outcomes in pediatric cystic fibrosis.

Matthew M Willmering1, David J Roach1, Elizabeth L Kramer2, Laura L Walkup3, Zackary I Cleveland3, Jason C Woods4.   

Abstract

BACKGROUND: Two functional measurements (multiple breath washout [MBW] and hyperpolarized 129Xe ventilation magnetic resonance imaging [129Xe MRI]) have been shown to be more sensitive to cystic fibrosis (CF) lung obstruction than traditional spirometry. However, functional techniques may be sensitive to different underlying structural abnormalities. The purpose of this study was to determine relationships between these functional markers, their pathophysiology, and 1-year clinical outcomes.
METHODS: Spirometry, MBW, 129Xe MRI, and ultrashort echo-time (UTE) MRI were obtained in a same-day assessment of 27 pediatric CF patients (ages 11.5±5.0) who had not begun CFTR modulator therapies. UTE MRI was scored for structural abnormalities and functional metrics obtained via spirometry, MBW and 129Xe MRI. 1-year outcomes (ΔFEV1 and pulmonary exacerbations), during which ≈50% initiated modulator therapy, were obtained from the electronic medical record.
RESULTS: MBW, 129Xe MRI, and UTE MRI detected clinically significant disease in more subjects (>78%) compared to spirometry (<30%). UTE MRI suggests increased odds of bronchial changes when mucus plugging is present in the same lobe. MBW and 129Xe MRI correlated best with mucus plugging, while spirometry correlated best with consolidations. Bronchial abnormalities were associated with future pulmonary exacerbations.
CONCLUSIONS: MBW, 129Xe MRI, and UTE MRI are more sensitive for detection of pediatric CF lung disease when compared to spirometry. MBW and 129Xe MRI correlated with structural abnormalities which occur in early CF disease, suggesting MBW and 129Xe MRI are valuable tools in mild CF lung disease that can guide clinical decision making.
Copyright © 2020 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Function; MRI; Multiple breath washout; Spirometry; Structure; Xenon

Mesh:

Substances:

Year:  2020        PMID: 33288474      PMCID: PMC8175447          DOI: 10.1016/j.jcf.2020.11.019

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  29 in total

1.  Morphologic and functional scoring of cystic fibrosis lung disease using MRI.

Authors:  Monika Eichinger; Daiva-Elzbieta Optazaite; Annette Kopp-Schneider; Christian Hintze; Jürgen Biederer; Anne Niemann; Marcus A Mall; Mark O Wielpütz; Hans-Ulrich Kauczor; Michael Puderbach
Journal:  Eur J Radiol       Date:  2011-03-23       Impact factor: 3.528

2.  Detection of early subclinical lung disease in children with cystic fibrosis by lung ventilation imaging with hyperpolarised gas MRI.

Authors:  Helen Marshall; Alex Horsley; Chris J Taylor; Laurie Smith; David Hughes; Felix C Horn; Andrew J Swift; Juan Parra-Robles; Paul J Hughes; Graham Norquay; Neil J Stewart; Guilhem J Collier; Dawn Teare; Steve Cunningham; Ina Aldag; Jim M Wild
Journal:  Thorax       Date:  2017-03-06       Impact factor: 9.139

3.  A two-center analysis of hyperpolarized 129Xe lung MRI in stable pediatric cystic fibrosis: Potential as a biomarker for multi-site trials.

Authors:  Marcus J Couch; Robert Thomen; Nikhil Kanhere; Raymond Hu; Felix Ratjen; Jason Woods; Giles Santyr
Journal:  J Cyst Fibros       Date:  2019-03-25       Impact factor: 5.482

4.  Regional ventilation changes in severe asthma after bronchial thermoplasty with (3)He MR imaging and CT.

Authors:  Robert P Thomen; Ajay Sheshadri; James D Quirk; Jim Kozlowski; Henry D Ellison; Rhonda D Szczesniak; Mario Castro; Jason C Woods
Journal:  Radiology       Date:  2014-08-19       Impact factor: 11.105

5.  PRAGMA-CF. A Quantitative Structural Lung Disease Computed Tomography Outcome in Young Children with Cystic Fibrosis.

Authors:  Tim Rosenow; Merel C J Oudraad; Conor P Murray; Lidija Turkovic; Wieying Kuo; Marleen de Bruijne; Sarath C Ranganathan; Harm A W M Tiddens; Stephen M Stick
Journal:  Am J Respir Crit Care Med       Date:  2015-05-15       Impact factor: 21.405

6.  Regional Structure-Function in Cystic Fibrosis Lung Disease Using Hyperpolarized 129Xe and Ultrashort Echo Magnetic Resonance Imaging.

Authors:  Robert P Thomen; Laura L Walkup; David J Roach; Nara Higano; Andrew Schapiro; Alan Brody; John P Clancy; Zackary I Cleveland; Jason C Woods
Journal:  Am J Respir Crit Care Med       Date:  2020-07-15       Impact factor: 21.405

7.  Hyperpolarised 129Xe magnetic resonance imaging to monitor treatment response in children with cystic fibrosis.

Authors:  Jonathan H Rayment; Marcus J Couch; Nancy McDonald; Nikhil Kanhere; David Manson; Giles Santyr; Felix Ratjen
Journal:  Eur Respir J       Date:  2019-05-02       Impact factor: 16.671

8.  Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline.

Authors:  Padmaja Subbarao; Sanja Stanojevic; Meghan Brown; Renee Jensen; Margaret Rosenfeld; Stephanie Davis; Lyndia Brumback; Per Gustafsson; Felix Ratjen
Journal:  Am J Respir Crit Care Med       Date:  2013-08-15       Impact factor: 21.405

Review 9.  Scoring of chest CT in children with cystic fibrosis: state of the art.

Authors:  Alistair D Calder; Andrew Bush; Alan S Brody; Catherine M Owens
Journal:  Pediatr Radiol       Date:  2014-08-28

10.  3D ultrashort echo time MRI of the lung using stack-of-spirals and spherical k-Space coverages: Evaluation in healthy volunteers and parenchymal diseases.

Authors:  Gaël Dournes; Joseph Yazbek; Wadie Benhassen; Ilyes Benlala; Elodie Blanchard; Marie-Elise Truchetet; Julie Macey; Patrick Berger; François Laurent
Journal:  J Magn Reson Imaging       Date:  2018-09-11       Impact factor: 4.813

View more
  3 in total

1.  Bias field correction in hyperpolarized 129 Xe ventilation MRI using templates derived by RF-depolarization mapping.

Authors:  Junlan Lu; Ziyi Wang; Elianna Bier; Suphachart Leewiwatwong; David Mummy; Bastiaan Driehuys
Journal:  Magn Reson Med       Date:  2022-05-04       Impact factor: 3.737

Review 2.  Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis.

Authors:  Mirjam Stahl; Eva Steinke; Marcus A Mall
Journal:  Genes (Basel)       Date:  2021-05-25       Impact factor: 4.096

Review 3.  Lung MRI with hyperpolarised gases: current & future clinical perspectives.

Authors:  Neil J Stewart; Laurie J Smith; Ho-Fung Chan; James A Eaden; Smitha Rajaram; Andrew J Swift; Nicholas D Weatherley; Alberto Biancardi; Guilhem J Collier; David Hughes; Gill Klafkowski; Christopher S Johns; Noreen West; Kelechi Ugonna; Stephen M Bianchi; Rod Lawson; Ian Sabroe; Helen Marshall; Jim M Wild
Journal:  Br J Radiol       Date:  2021-06-09       Impact factor: 3.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.